NCT06895525View on ClinicalTrials.gov

Efficacy of HellenCare in Early-Stage Alzheimer's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Alzheimer's Disease Dementia
Interventions
DIETARY_SUPPLEMENT

HellenCare

2 g, twice daily, to be taken on an empty stomach.

DIETARY_SUPPLEMENT

Placebo

2 g, twice daily, to be taken on an empty stomach.

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT06895525 - Efficacy of HellenCare in Early-Stage Alzheimer's Disease | Biotech Hunter | Biotech Hunter